PharmaShots | Incisive News in 3 Shots

Subscribe Now

metastatic castration-sensitive prostate cancer

Janssen's Erleada (apalutamide) Receives Health Canada's Approval for Metastatic Castration-Sensitive Prostate Cancer

Janssen's Erleada (apalutamide) Receives Health Canada's Approval for Metastatic Castration-Sensitive Prostate Cancer

December 17, 2019

Janssen (J&J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cancer (mCSPC) #ASCO2019

Janssen (J&J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cance...

January 31, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us